Please enable Javascript

Labmeeting uses lots of Javascript - basically you can't use the site without it. So please enable Javascript in your browser. If your browser does not support Javascript, we recommend Firefox.

Papers authored by Crémieux PY

Collect these papers and discover other ones on Labmeeting. Learn more.

The economic implications of generic substitution of antiepileptic drugs: a review of recent evidence.

+ cite this

+ View Abstract

Duh MS, Cahill KE, Paradis PE, Cremieux PY, and Greenberg PE

Expert opinion on pharmacotherapy 10(14):2317-28, 2009 Oct - Who cited this? | PubMed ID: 19663636 | Fulltext

Exact and efficient inference procedure for meta-analysis and its application to the analysis of independent 2 x 2 tables with all available data but without artificial continuity correction.

+ cite this

+ View Abstract

Tian L, Cai T, Pfeffer MA, Piankov N, Cremieux PY, and Wei LJ

Biostatistics (Oxford, England) 10(2):275-81, 2009 Apr - Who cited this? | PubMed ID: 18922759 | Fulltext

Economic impact of multiple sclerosis disease-modifying drugs in an employed population: direct and indirect costs.

+ cite this

+ View Abstract

Birnbaum HG, Ivanova JI, Samuels S, Davis M, Cremieux PY, Phillips AL, and Meletiche D

Current medical research and opinion 25(4):869-77, 2009 Apr - Who cited this? | PubMed ID: 19232041 | Fulltext

Return on investment for bariatric surgery.

+ cite this

Crémieux PY, Ghosh A, Yang HE, Buessing M, Buchwald H, and Shikora SA

The American journal of managed care 14(11):e5-6, 2008 Nov - Who cited this? | PubMed ID: 19009734 | Fulltext

A study on the economic impact of bariatric surgery.

+ cite this

+ View Abstract

Cremieux PY, Buchwald H, Shikora SA, Ghosh A, Yang HE, and Buessing M

The American journal of managed care 14(9):589-96, 2008 Sep - Who cited this? | PubMed ID: 18778174 | Fulltext

The economic consequences of generic substitution for antiepileptic drugs in a public payer setting: the case of lamotrigine.

+ cite this

+ View Abstract

Duh MS, Andermann F, Paradis PE, Weiner J, Manjunath R, and Crémieux PY

Disease management : DM 10(4):216-25, 2007 Aug - Who cited this? | PubMed ID: 17718660 | Fulltext

Do drugs reduce utilisation of other healthcare resources?.

+ cite this

+ View Abstract

Crémieux PY, Ouellette P, and Petit P

PharmacoEconomics 25(3):209-21, 2007 - Who cited this? | PubMed ID: 17335307 | Fulltext

The economic impact of a partnership-measurement model of disease management: Improving Cardiovascular Outcomes in Nova Scotia (ICONS).

+ cite this

+ View Abstract

Crémieux PY, Fortin P, Meilleur MC, Montague T, and Royer J

Healthcare quarterly (Toronto, Ont.) 10(2):38-46, 2007 - Who cited this? | PubMed ID: 17491566 | Fulltext

The relative dosing of epoetin alfa and darbepoetin alfa in chronic kidney disease.

+ cite this

+ View Abstract

Cremieux PY, Van Audenrode M, and Lefebvre P

Current medical research and opinion 22(12):2329-36, 2006 Dec - Who cited this? | PubMed ID: 17257447 | Fulltext

Relationship between hemoglobin level and quality of life in anemic patients with chronic kidney disease receiving epoetin alfa.

+ cite this

+ View Abstract

Lefebvre P, Vekeman F, Sarokhan B, Enny C, Provenzano R, and Cremieux PY

Current medical research and opinion 22(10):1929-37, 2006 Oct - Who cited this? | PubMed ID: 17022852 | Fulltext

Hospital cost flexibility in the presence of many outputs: a public-private comparison.

+ cite this

+ View Abstract

Crémieux PY, Ouellette P, Rimbaud F, and Vigeant S

Health care management science 8(2):111-20, 2005 May - Who cited this? | PubMed ID: 15952608 | Fulltext

Public and private pharmaceutical spending as determinants of health outcomes in Canada.

+ cite this

+ View Abstract

Crémieux PY, Meilleur MC, Ouellette P, Petit P, Zelder M, and Potvin K

Health economics 14(2):107-16, 2005 Feb - Who cited this? | PubMed ID: 15386658 | Fulltext

Dose conversion and cost effectiveness of erythropoietic therapies in chemotherapy-related anaemia : a meta-analysis.

+ cite this

+ View Abstract

Rosberg JH, Ben-Hamadi R, Cremieux PY, Fastenau JM, and Piech CT

Clinical drug investigation 25(1):33-48, 2005 - Who cited this? | PubMed ID: 17523745 | Fulltext

Incidence and costs of accidents among attention-deficit/hyperactivity disorder patients.

+ cite this

+ View Abstract

Swensen A, Birnbaum HG, Ben Hamadi R, Greenberg P, Cremieux PY, and Secnik K

The Journal of adolescent health : official publication of the Society for Adolescent Medicine 35(4):346.e1-9, 2004 Oct - Who cited this? | PubMed ID: 15830457 | Fulltext

Cost-minimization analysis of once-weekly versus thrice-weekly epoetin alfa for chemotherapy-related anemia.

+ cite this

+ View Abstract

Crémieux PY, Fastenau JM, Kosicki G, Piech CT, and Fendrick AM

Journal of managed care pharmacy : JMCP 10(6):531-7, 2004 - Who cited this? | PubMed ID: 15548125 | Fulltext

Dose conversion from epoetin alfa to darbepoetin alfa for patients with chronic kidney disease receiving hemodialysis.

+ cite this

Barnett AL and Crémieux PY

Pharmacotherapy 23(5):690-3; discussion 693-4, 2003 May - Who cited this? | PubMed ID: 12741447 | Fulltext

Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy.

+ cite this

+ View Abstract

Crawford J, Cella D, Cleeland CS, Cremieux PY, Demetri GD, Sarokhan BJ, Slavin MB, and Glaspy JA

Cancer 95(4):888-95, 2002 Aug 15 - Who cited this? | PubMed ID: 12209734 | Fulltext

Actual and perceived impacts of tobacco regulation on restaurants and firms.

+ cite this

+ View Abstract

Crémieux PY and Ouellette P

Tobacco control 10(1):33-7, 2001 Mar - Who cited this? | PubMed ID: 11226358 | Fulltext

Omitted variable bias and hospital costs.

+ cite this

+ View Abstract

Crémieux PY and Ouellette P

Journal of health economics 20(2):271-82, 2001 Mar - Who cited this? | PubMed ID: 11252374 | Fulltext

The costs of cancer to a major employer in the United States: a case-control analysis.

+ cite this

+ View Abstract

Barnett A, Birnbaum H, Cremieux PY, Fendrick AM, and Slavin M

The American journal of managed care 6(11):1243-51, 2000 Nov - Who cited this? | PubMed ID: 11185849 | Fulltext

Cost of outpatient blood transfusion in cancer patients.

+ cite this

+ View Abstract

Crémieux PY, Barrett B, Anderson K, and Slavin MB

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 18(14):2755-61, 2000 Jul - Who cited this? | PubMed ID: 10894876 | Fulltext

Health care spending as determinants of health outcomes.

+ cite this

+ View Abstract

Crémieux PY, Ouellette P, and Pilon C

Health economics 8(7):627-39, 1999 Nov - Who cited this? | PubMed ID: 10544328 | Fulltext

Pharmacoeconomics and health policy. Current applications and prospects for the future.

+ cite this

+ View Abstract

Greenberg PE, Arcelus A, Birnbaum HG, Cremieux PY, LeLorier J, Ouellette P, and Slavin MB

PharmacoEconomics 16(5 Pt 1):425-32, 1999 Nov - Who cited this? | PubMed ID: 10662390 | Fulltext

Cost effectiveness, quality-adjusted life-years and supportive care. Recombinant human erythropoietin as a treatment of cancer-associated anaemia.

+ cite this

+ View Abstract

Cremieux PY, Finkelstein SN, Berndt ER, Crawford J, and Slavin MB

PharmacoEconomics 16(5 Pt 1):459-72, 1999 Nov - Who cited this? | PubMed ID: 10662393 | Fulltext

Using healthcare claims data for outcomes research and pharmacoeconomic analyses.

+ cite this

+ View Abstract

Birnbaum HG, Cremieux PY, Greenberg PE, LeLorier J, Ostrander JA, and Venditti L

PharmacoEconomics 16(1):1-8, 1999 Jul - Who cited this? | PubMed ID: 10539118 | Fulltext

Search Google Scholar for Crémieux PY

Join Labmeeting

Organize and search your PDF collection
Collect papers
Search millions of papers
Keep up to date with paper alerts
Read your papers from anywhere
Recommend papers to colleagues
Manage your lab

Labmeeting is a web service for researchers. Sign up with your academic email address.

Individuals or corporations not affiliated with an academic institution can request a trial subscription.

Got a question?
The Labmeeting Network
has the answer.
Ask scientists at top universities like Harvard, Stanford, and MIT for their expert opinion!